Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Ann Rheum Dis. 2021 Nov; 80(11):1436-1444.

Objectives:

To compare the benefits of a tight-control/treat-to-target strategy (TC/T2T) in axial spondyloarthritis (axSpA) with those of usual care (UC).

 

https://pubmed.ncbi.nlm.nih.gov/33958325/

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates
Publications - Rhumatologie - Facultatif

Publication Bias in Drug Safety: RCTs Study on Bisphosphonates

Arrêt long cours anti-ostéoporotiques en France
Publications - Rhumatologie

Arrêt long cours anti-ostéoporotiques en France

Publication bias overestimates risk in bisphosphonates
Publications - Rhumatologie

Publication bias overestimates risk in bisphosphonates